Disparities in the access to immune checkpoint inhibitors approved in the United States, the European Union and mainland China: a serial cross-sectional study

Background Immune checkpoint inhibitors (ICIs) have revolutionised antitumour therapy. However, regional differences in ICI labels, including the impact of the review process and supporting trial evidence, remain unclear.Methods We conducted a serial cross-sectional study to examine trends and diffe...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jin-Ling Tang, Hao Hu, Carolina Oi Lam Ung, Shi-Yu Wang, Jia-Xin Cai, Fu-Xiao Li, Teng-Fei Lin, Shi-Fu Luo, Hai-Bo Song, Zhi-Rong Yang, Wei-Hua Meng
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 2025-05-01
coleção:	BMJ Public Health
Acesso em linha:	https://bmjpublichealth.bmj.com/content/3/1/e001995.full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!